2018
-
Press release2018-09-13MMMM DD, YYYYSanofi to refocus two global business units
-
Press release2018-05-21MMMM DD, YYYYSanofi Appoints Amal Makhloufi Benchouk
-
Press release2018-05-14MMMM DD, YYYYSanofi and Ablynx Announce the Successful Results of the Initial Tender Offer
-
-
Press release2018-04-19MMMM DD, YYYYSanofi Pasteur communication on SAGE recommendation about dengue vaccine
-
Press release2018-04-17MMMM DD, YYYYAdvent International enters into exclusive negotiations to acquire Sentiva, Sanofi's european generics business
-
Press release2018-04-01MMMM DD, YYYYSanofi to invest €350 million in Canadian vaccine facility
-
Press release2018-03-29MMMM DD, YYYYTender Offers by Sanofi to acquire Ablynx
-
Press release2018-03-18MMMM DD, YYYYEvotec and Sanofi in exclusive talks to create an Evotec-led Infectious Disease open innovation R&D platform
-
-
Press release2018-03-08MMMM DD, YYYYSanofi completes acquisition of Bioverativ
-
-
Press release2018-01-29MMMM DD, YYYYSanofi to acquire Ablynx for €3.9 billion
-
-
Press release2018-01-08MMMM DD, YYYYSanofi Investor Agreement Release
2017
-
Press release2017-12-04MMMM DD, YYYYSanofi’s Toujeo® met main objective in head-to-head study versus insulin degludec
-
Press release2017-12-04MMMM DD, YYYYSanofi updates information on dengue vaccine in Philippines
-
Press release2017-11-29MMMM DD, YYYYSanofi updates information on dengue vaccine
-
Press release2017-10-24MMMM DD, YYYYSanofi Files Suit in the U.S. to Defend Its Patent Rights on Lantus® and Lantus® SoloStar®
-
Press release2017-10-12MMMM DD, YYYYSanofi invests €170 million in new vaccine production facility in France